Cargando…

Immune checkpoint inhibitors: recent progress and potential biomarkers

Cancer growth and progression are associated with immune suppression. Cancer cells have the ability to activate different immune checkpoint pathways that harbor immunosuppressive functions. Monoclonal antibodies that target immune checkpoints provided an immense breakthrough in cancer therapeutics....

Descripción completa

Detalles Bibliográficos
Autores principales:	Darvin, Pramod, Toor, Salman M., Sasidharan Nair, Varun, Elkord, Eyad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292890/ https://www.ncbi.nlm.nih.gov/pubmed/30546008 http://dx.doi.org/10.1038/s12276-018-0191-1

Ejemplares similares

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020)

PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications
por: Darvin, Pramod, et al.
Publicado: (2019)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Toor, Salman M., et al.
Publicado: (2020)

Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
por: Saleh, Reem, et al.
Publicado: (2020)

T‐cell responses and therapies against SARS‐CoV‐2 infection
por: Toor, Salman M., et al.
Publicado: (2020)

Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients
por: Shaath, Hibah, et al.
Publicado: (2019)

Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

Editorial: Understanding mitochondrial dynamics and metabolic plasticity in cancer stem cells: Recent advances in cancer treatment and potential therapeutic approaches
por: Darvin, Pramod, et al.
Publicado: (2023)

Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
por: Saleh, Reem, et al.
Publicado: (2020)

DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
por: Sasidharan Nair, Varun, et al.
Publicado: (2018)

Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors
por: Toor, Salman M., et al.
Publicado: (2021)

DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR(–) myeloid cells, compared with HLA-DR(+) antigen-presenting cells
por: Saleh, Reem, et al.
Publicado: (2020)

T-Regulatory Cells in Health and Disease
por: Elkord, Eyad, et al.
Publicado: (2018)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4(+) T Cells
por: Saleh, Reem, et al.
Publicado: (2019)

Differential gene expression of tumor-infiltrating CD33(+) myeloid cells in advanced- versus early-stage colorectal cancer
por: Toor, Salman M., et al.
Publicado: (2020)

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets in Colorectal Cancer Patients
por: Toor, Salman M., et al.
Publicado: (2019)

Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers
por: Toor, Salman M., et al.
Publicado: (2017)

Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8(+) Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
por: Alsalman, Alhasan, et al.
Publicado: (2022)

Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2019)

Differential gene expression of tumor-infiltrating CD4(+) T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
por: Saleh, Reem, et al.
Publicado: (2019)

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
por: Thomas, Remy, et al.
Publicado: (2020)

Differential gene expression of tumor-infiltrating CD8(+) T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis
por: Saleh, Reem, et al.
Publicado: (2020)

Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4(+) T Cells Associated with Poor Disease-Specific Survival
por: Toor, Salman M., et al.
Publicado: (2021)

Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
por: Alahdal, Murad, et al.
Publicado: (2023)

Transcriptomic Profiling of Tumor-Infiltrating CD4(+)TIM-3(+) T Cells Reveals Their Suppressive, Exhausted, and Metastatic Characteristics in Colorectal Cancer Patients
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
por: Chaudhary, Belal, et al.
Publicado: (2016)

Correlations between Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets with Immune Checkpoints in Colorectal Cancer
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
por: Sasidharan Nair, Varun, et al.
Publicado: (2018)

Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages
por: Toor, Salman M., et al.
Publicado: (2020)

Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections
por: Alahdal, Murad, et al.
Publicado: (2022)

Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer
por: Shaath, Hibah, et al.
Publicado: (2021)

Correlations between Circulating and Tumor-Infiltrating CD4(+) Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
por: Alahdal, Murad, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials
por: Li, Bin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uhj43eqifoj11ti2v9icakdv6r